Diverse changes in albuminuria during treatment of essential hypertensives with an angiotensin-converting enzyme inhibitor or a calcium channel blocker

被引：0
|
作者：
Lasaridis, A [1 ]
Kopras, A [1 ]
Zebekakis, P [1 ]
Sarafidis, P [1 ]
Metallidis, S [1 ]
Tziolas, I [1 ]
Hatzistavri, L [1 ]
Diamantopoulos, A [1 ]
Kevrekidou, A [1 ]
机构：
[1] Univ Hosp, AHEPA, Thessaloniki, Greece
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [31] Clinical Factors and Rate of Cough During Angiotensin-Converting Enzyme Inhibitor Treatment
    Ren, Huan
    Luo, Jian-Quan
    Shu, Yan
    Zhou, Hong-Hao
    Zhang, Wei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (03) : 566 - 566
  • [32] Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension
    Jamerson, KA
    Nwose, O
    Jean-Louis, L
    Schofield, L
    Purkayastha, D
    Baron, M
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (06) : 495 - 501
  • [33] Calcium channel blocker and angiotensin converting enzyme inhibitor suppress central cholinergic nerve activity in hypertension
    Tsuda, K
    Kimura, K
    Nishio, I
    JOURNAL OF HYPERTENSION, 2002, 20 : S134 - S135
  • [34] Fixed combination of the calcium channel blocker lercanidipine and angiotensin converting enzyme inhibitor enalapril: possibility of usage
    Ostroumova, O. D.
    Kopchenov, I. I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (02) : 177 - 182
  • [35] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [37] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [38] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [39] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [40] Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension
    Remková, A
    Kratochvíl'ová, H
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (07) : 641 - 644
12345